Survival after intestinal perforation: Can it be predicted?

Gynecologic Oncology

Volumn 115, Issue 3, 2009, Pages 349-353

  Tung, Celestine S ^a   Sun, Charlotte C ^a   Schlumbrecht, Matthew P ^a   Meyer, Larissa A ^a   Bodurka, Diane C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

APACHE II; Intestinal perforation; Prognostic factor; Survival

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; PACLITAXEL;

ABDOMINAL SURGERY; ADULT; AGED; APACHE; ARTICLE; BODY MASS; CANCER RADIOTHERAPY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GYNECOLOGIC CANCER; HUMAN; INTESTINE PERFORATION; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INTESTINAL PERFORATION; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 70350568741     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.08.013     Document Type: Article

References (26)

1. Bielecki K., Kaminski P., and Klukowski M. Large bowel perforation: morbidity and mortality. Tech. Coloproctol. 6 (2002) 177-182
2. Torosian M.H., and Turnbull A.D. Emergency laparotomy for spontaneous intestinal and colonic perforations in cancer patients receiving corticosteroids and chemotherapy. J. Clin. Oncol. 6 (1988) 291-296
3. Nespoli A., Ravizzini C., Trivella M., and Segala M. The choice of surgical procedure for peritonitis due to colonic perforation. Arch. Surg. 128 (1993) 814-818
4. Yamazawa K., Matsui H., and Sekiya S. Gastric perforation induced by combination chemotherapy in a patient with long-term use of corticosteroids. Int. J. Gynaecol. Obstet. 78 (2002) 165-166
5. Ramirez P.T., Levenback C., Burke T.W., Eifel P., Wolf J.K., and Gershenson D.M. Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol. Oncol. 82 (2001) 150-155
6. Yamashita H., Nakagawa K., Tago M., Igaki H., Shiraishi K., Nakamura N., et al. Small bowel perforation without tumor recurrence after radiotherapy for cervical carcinoma: report of seven cases. J. Obstet. Gynaecol. Res. 32 (2006) 235-242
7. Seewaldt V.L., Cain J.M., Goff B.A., Tamimi H., Greer B., and Figge D. A retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian cancer. Gynecol. Oncol. 67 (1997) 137-140
8. Rose P.G., and Piver M.S. Intestinal perforation secondary to paclitaxel. Gynecol. Oncol. 57 (1995) 270-272
9. de Haan D., and van den Berg M. Colonic perforation secondary to taxol therapy: an unusual presentation. Onkologie 29 (2006) 541-542
10. Kouroussis C., Samonis G., Androulakis N., Souglakos J., Voloudaki A., Dimopoulos M.A., et al. Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases. Am. J. Clin. Oncol. 23 (2000) 309-313
11. Han E.S., and Monk B.J. What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?. Gynecol. Oncol. 105 (2007) 3-6
12. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 13 (1985) 818-829
13. Komatsu S., Shimomatsuya T., Nakajima M., Amaya H., Kobuchi T., Shiraishi S., et al. Prognostic factors and scoring system for survival in colonic perforation. Hepatogastroenterology 52 (2005) 761-764
14. Kulkarni S.V., Naik A.S., and Subramanian Jr. N. APACHE-II scoring system in perforative peritonitis. Am. J. Surg. 194 (2007) 549-552
15. Ohmann C., Wittmann D.H., and Wacha H. Prospective evaluation of prognostic scoring systems in peritonitis. Peritonitis Study Group. Eur. J. Surg. 159 (1993) 267-274
16. Kologlu M., Elker D., Altun H., and Sayek I. Validation of MPI and PIA II in two different groups of patients with secondary peritonitis. Hepatogastroenterology 48 (2001) 147-151
17. Knaus W.A., Zimmerman J.E., Wagner D.P., Draper E.A., and Lawrence D.E. APACHE-Acute Physiology and Chronic Health Evaluation: a physiologically based classification system. Crit. Care Med. 9 (1981) 591-597
18. Larvin M., and McMahon M.J. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 2 (1989) 201-205
19. Hsieh H.F., Chen T.W., Yu C.Y., Wang N.C., Chu H.C., Shih M.L., et al. Aggressive hepatic resection for patients with pyogenic liver abscess and APACHE II score > or = 15. Am. J. Surg. 196 (2008) 346-350
20. Han S.H., Chin B.S., Lee H.S., Jeong S.J., Choi H.K., Kim C.O., et al. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome. J. Infect. 58 (2009) 182-190
21. Lee F.Y., Leung K.L., Lai B.S., Ng S.S., Dexter S., and Lau W.Y. Predicting mortality and morbidity of patients operated on for perforated peptic ulcers. Arch. Surg. 136 (2001) 90-94
22. Ohmann C., and Hau T. Prognostic indices in peritonitis. Hepatogastroenterology 44 (1997) 937-946
23. Rutledge R., Fakhry S.M., Rutherford E.J., Muakkassa F., Baker C.C., Koruda M., et al. Acute Physiology and Chronic Health Evaluation (APACHE II) score and outcome in the surgical intensive care unit: an analysis of multiple intervention and outcome variables in 1,238 patients. Crit. Care Med. 19 (1991) 1048-1053
24. Marks R.J., Simons R.S., Blizzard R.A., and Browne D.R. Predicting outcome in intensive therapy units-a comparison of APACHE II with subjective assessments. Intensive Care Med. 17 (1991) 159-163
25. Horiuchi A., Watanabe Y., Doi T., Sato K., Yukumi S., Yoshida M., et al. Evaluation of prognostic factors and scoring system in colonic perforation. World J. Gastroenterol. 13 (2007) 3228-3231
26. Levison M.A., and Zeigler D. Correlation of APACHE II score, drainage technique and outcome in postoperative intra-abdominal abscess. Surg. Gynecol. Obstet. 172 (1991) 89-94